News

Kestra Medical Technologies Showcases Innovative Cardiac Solutions

Kestra Medical Technologies Showcases Innovative Cardiac Solutions

Presenting Cutting-Edge Cardiac Innovations at AHA 2025

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS), a pioneer in wearable medical devices, has recently announced its involvement in the American Heart Association (AHA) Scientific Sessions 2025. This event is taking place from November 7 to 10, showcasing a pivotal advancement in cardiac care through a late-breaking science presentation.

Understanding the ACE-PAS Trial

During the AHA event, Kestra will unveil primary results from the crucial ACE-PAS Trial, officially known as the Post-Approval Study of a Next Generation Wearable Cardioverter Defibrillator System. This significant presentation is set to occur on November 10 at 8:44 a.m. CT.

Largest Study of Its Kind

The ACE-PAS Trial is unique in its scope, with over 20,000 patients enrolled to evaluate the real-world effectiveness of the next-generation wearable cardioverter defibrillator system. Being the largest prospective study of its kind, the ACE-PAS focuses on critical factors such as shock conversion success and rates of inappropriate shocks.

Key Findings and Impacts

The trial is designed to gather extensive data that includes initial shock conversion success and the average daily wear time. These insights illustrate the growing impact of wearable technology in improving outcomes for patients at risk of sudden cardiac events. By being featured in AHA's late-breaking science program, this research highlights the essential role of data-driven approaches in shaping modern cardiac care.

Insights from Leadership

Brian Webster, the President and CEO of Kestra Medical Technologies, expressed pride in being selected for such a prestigious presentation. He emphasized how this recognition underscores the importance of the ACE-PAS study and the company's innovative technology. As the landscape of cardiac recovery continuously evolves, Kestra is redefining monitoring and treatment through advanced digital health integration.

Explore Innovative Solutions at AHA

Attendees at the AHA 2025 can visit Kestra's booth (#4617) to experience the Kestra Cardiac Recovery System. This system incorporates the ASSURE® Wearable Cardioverter Defibrillator, combining reliable patient safety features with essential clinical insights. This integration allows healthcare providers to enhance guideline-directed therapies and support patients' long-term recovery journeys.

Engagement at the Event

Beyond their late-breaking presentation, Kestra will facilitate live demonstrations and engaging discussions throughout the conference. Their booth will feature an immersive experience that highlights their commitment to connected and data-driven cardiac recovery solutions, showcasing the future of heart health technologies.

About Kestra Medical Technologies

Kestra Medical Technologies is dedicated to enhancing patient outcomes in cardiovascular care by leveraging intuitive and connected therapeutic interventions. Their innovative approaches aim to transform how patients manage cardiovascular conditions while aiming to improve healthcare delivery across the board. For further details, please visit www.kestramedical.com.

Frequently Asked Questions

What is the ACE-PAS Trial?

The ACE-PAS Trial evaluates the effectiveness of a next-generation wearable cardioverter defibrillator by studying its real-world application with over 20,000 patients.

When will the results be presented?

The primary results from the ACE-PAS Trial will be presented on November 10 at 8:44 a.m. CT during the AHA Scientific Sessions 2025.

What is the significance of this study?

This study is significant because it represents the largest prospective study on wearable cardioverter defibrillators, demonstrating their efficacy in real-world settings and broadening understanding of sudden cardiac event management.

How does Kestra's technology improve patient care?

Kestra's technology integrates monitoring and therapeutic solutions that provide healthcare professionals with data-driven insights, enhancing patient safety and recovery strategies.

Where can I learn more about Kestra Medical Technologies?

For more information about their innovative solutions and commitment to cardiac care, please visit www.kestramedical.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 176

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 218

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 284

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 237

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 201

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 35

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 85

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 189

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading

Top 5 Most Recently Viewed Articles

Greenwave Technology Solutions CEO Discusses Scrap Metal Growth

Updated Category News Views 153

Greenwave Technology Solutions, Inc. CEO to be Featured on BNN Bloomberg Greenwave Technology Solutions, Inc. (NASDAQ: GWAV) is preparing for a significant media appearance that is set to shed light on the scrap metal industry and its promising future. CEO Danny Meeks is expected to be interviewed on BNN Bloomberg, providing insights into the company’s strategic...

Continue Reading
Exploring China's Transformation: A Look at Progress and Change

Updated Category News Views 207

China isn’t just a big country; it’s a beast that’s undergone an awe-inspiring metamorphosis over the decades. From ancient civilization whispers to a modern superpower roar, this nation has seen changes that make your head spin. As we close in on 75 years since the People's Republic was birthed, China's impressive transformation is undeniable. The China...

Continue Reading
Orion Group Holdings Launches $25 Million Common Stock Offering

Updated Category News Views 41

Orion Group Holdings Announces Public Offering Orion Group Holdings, Inc. (NYSE: ORN) has made a notable announcement about its new public offering of common stock. This move is part of the company's strategy to strengthen its financial base and enhance its operational capabilities in the construction industry. The offering includes 4,860,000 shares priced at $5.15 each,...

Continue Reading
Gaotu Techedu Inc. Set to Reveal Q4 and Fiscal Year Results

Updated Category News Views 109

Gaotu Techedu Inc. to Announce Quarterly Financial Results Gaotu Techedu Inc. (NYSE: GOTU), a prominent education technology company, recently disclosed plans to announce its financial results for the fourth quarter and the entire fiscal year 2024. This announcement will occur before the opening of U.S. markets on February 26. Investors and stakeholders are eager to learn...

Continue Reading
Chicago Atlantic Real Estate Finance Announces Q2 Results Date

Updated Category News Views 116

Chicago Atlantic Real Estate Finance Announces Q2 Earnings Release Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI), a prominent commercial mortgage real estate investment trust, has made significant announcements regarding its upcoming earnings report. Schedule for Earnings Release and Conference Call On a notable date of August 7, the Company plans to release...

Continue Reading